Correlation Between Zealand Pharma and Wirtek AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zealand Pharma and Wirtek AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zealand Pharma and Wirtek AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zealand Pharma AS and Wirtek AS, you can compare the effects of market volatilities on Zealand Pharma and Wirtek AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zealand Pharma with a short position of Wirtek AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zealand Pharma and Wirtek AS.

Diversification Opportunities for Zealand Pharma and Wirtek AS

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Zealand and Wirtek is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Zealand Pharma AS and Wirtek AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wirtek AS and Zealand Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zealand Pharma AS are associated (or correlated) with Wirtek AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wirtek AS has no effect on the direction of Zealand Pharma i.e., Zealand Pharma and Wirtek AS go up and down completely randomly.

Pair Corralation between Zealand Pharma and Wirtek AS

Assuming the 90 days trading horizon Zealand Pharma AS is expected to generate 1.24 times more return on investment than Wirtek AS. However, Zealand Pharma is 1.24 times more volatile than Wirtek AS. It trades about 0.07 of its potential returns per unit of risk. Wirtek AS is currently generating about -0.02 per unit of risk. If you would invest  28,200  in Zealand Pharma AS on December 7, 2024 and sell it today you would earn a total of  25,150  from holding Zealand Pharma AS or generate 89.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Zealand Pharma AS  vs.  Wirtek AS

 Performance 
       Timeline  
Zealand Pharma AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Wirtek AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Wirtek AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Zealand Pharma and Wirtek AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zealand Pharma and Wirtek AS

The main advantage of trading using opposite Zealand Pharma and Wirtek AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zealand Pharma position performs unexpectedly, Wirtek AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wirtek AS will offset losses from the drop in Wirtek AS's long position.
The idea behind Zealand Pharma AS and Wirtek AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency